The US Department of Agriculture recently approved the first human gene-containing commercial crops:
three strains of rice, engineered by California-based biotech company Ventria, that are spliced with genes coding for immune system proteins.
The plants are intended to be biological factories rather than actual dietary fare, with proteins extracted from the harvest and then added to medicine or food.
Many issues are contested here -- health, economics, intellectual property, safety, superstition -- and as experts chime in, we'll discuss them more in depth. For starters, Ventria has claimed that stray rice won't contaminate other crops. Such purity has so far been difficult to accomplish with other genetically engineered rice strains.
Rice Industry Troubled by Genetic Contamination [ Washington Post]